IDH1 and central nervous system cancer: Furthermore, we also found that the average age of glioma patients with IDH-mutant was significantly younger compared to glioma patients with IDH-wildtype (37.42 ± 10.54 vs. 48.40 ± 15.99, P = 0.000).